Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets close in 3 hrs 32 mins

S&P 500
5,968.40
+39.36(+0.66%)
Dow 30
43,768.39
+38.46(+0.09%)
Nasdaq
19,233.56
+250.09(+1.32%)
Russell 2000
2,394.38
+1.46(+0.06%)
Crude Oil
72.17
+0.48(+0.67%)
Gold
2,705.30
+29.00(+1.08%)

Alterity Therapeutics Limited (ATHE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

1.1700

-0.0400

(-3.31%)

As of 12:07PM EST. Market open.

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	10.45M
Enterprise Value	2.16M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	737.73
Price/Book (mrq)	1.16
Enterprise Value/Revenue	-1.18k
Enterprise Value/EBITDA	0.75

Trading Information

Stock Price History

Beta (5Y Monthly)	0.68
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	5.4100
52 Week Low ³	1.0100
50-Day Moving Average ³	1.2714
200-Day Moving Average ³	1.7149

Share Statistics

Avg Vol (3 month) ³	11.56k
Avg Vol (10 day) ³	11.13k
Shares Outstanding ⁵	8.74M
Implied Shares Outstanding ⁶	N/A
Float ⁸	3.73B
% Held by Insiders ¹	0.00%
% Held by Institutions ¹	1.16%
Shares Short (Oct 15, 2024) ⁴	6.22k
Short Ratio (Oct 15, 2024) ⁴	0.47
Short % of Float (Oct 15, 2024) ⁴	0.07%
Short % of Shares Outstanding (Oct 15, 2024) ⁴	0.07%
Shares Short (prior month Sep 13, 2024) ⁴	12.54k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:6
Last Split Date ³	Mar 24, 2016

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends	Jun 30, 2024
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-612.91%

Management Effectiveness

Return on Assets (ttm)	-52.66%
Return on Equity (ttm)	-104.47%

Income Statement

Revenue (ttm)	4.02M
Revenue Per Share (ttm)	0.60
Quarterly Revenue Growth (yoy)	38.40%
Gross Profit (ttm)	N/A
EBITDA	-19.57M
Net Income Avi to Common (ttm)	-19.12M
Diluted EPS (ttm)	-2.1400
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	12.64M
Total Cash Per Share (mrq)	0
Total Debt (mrq)	159.04k
Total Debt/Equity (mrq)	1.15
Current Ratio (mrq)	3.54
Book Value Per Share (mrq)	0.00

Cash Flow Statement

Operating Cash Flow (ttm)	-12.61M
Levered Free Cash Flow (ttm)	-5.36M